Avantis Medical Systems brings in $2.1M to detect cancer

Medical device company Avantis Medical Systems has raised $2.1 million of an expected $3.5 million in debt, options, warrants and other securities, according to a filing with the SEC. Based in Sunnyvale, Calif., the company’s devices aim to detect and prevent gastrointestinal cancer. Avantis last received $1.4M in 2009, and investors include BioStar Private Equity Fund, MedFocus Fund and Montreux Equity Partners.